Global Hyperbaric Oxygen Therapy Devices Market Size Likely to Grow at a CAGR of 4.9% By 2035

The market size of global hyperbaric oxygen therapy devices will be estimated at USD 3.89 billion in 2025 and is expected to grow to between USD 4.08 billion in 2026 and about USD 6.27 billion by 2035, with a current CAGR (compound annual growth rate) of 4.9% during the period of 2026 to 2035.

To learn more about this report - request a sample report PDF

Hyperbaric Oxygen Therapy Devices Market Revenue and Trends

Hyperbaric Oxygen Therapy (HBOT) is a medical system application in which the patient is exposed to higher-than-normal quantities of oxygen in a pressurized chamber, assisting the body in absorbing it. Normally the pressure in this chamber is increased and the patient is given oxygen to breathe at roughly a 100% concentration. These devices are mainly divided into monoplace chamber (for one patient) and multiplace chamber (for several patients at the same time). The FDA has classed hyperbaric chambers as Class II medical devices and requires pre-market supervision under 510(k).

The industrial trend is to make the HBOT devices as safe and smart as feasible. Today’s systems are increasingly automated and connected but also test the limits of safety. Digital displays, instrumentation, alarms and automated controls are used by some manufacturers to control and monitor the treatment. At the same time, special attention is paid to technological safety. In August 2025, the FDA warned against damage or death to patients who use hyperbaric devices. The issue was prevention of fires, elimination of ground faults, training, monitoring and maintenance.

What are the Factors That Have a Significant Contribution to the Growth of the Hyperbaric Oxygen Therapy Devices Market?

The increasing occurrence of chronic non-healing wounds is a major driving factor for the hyperbaric oxygen therapy devices market. This is mainly because patients suffering from serious wounds that do not respond to normal healing procedures may require hyperbaric oxygen therapy as an auxiliary treatment. As per the United States government figures, there were 40.1 million diabetic patients (diagnosed and undiagnosed) in the year 2023 itself. Further, the Center for Disease Control (CDC) estimates that 12% of all diabetic people would experience a diabetic foot ulcer throughout their lifetime. Importantly, the CDC also reports that 80% of all amputations are done on diabetes patients.

Chronic wounds are also of great concern, as there are roughly 6.5 million chronic wounds in America each year, according to a 2025 data report on wound treatment in the United States. Diabetic foot ulcers occur in 15-34% of diabetic people over their life periods. Therefore, diabetic foot ulcers and chronic wounds in general have a large cost influence on the health care system.

The necessity for hyperbaric oxygen therapy devices is a result of the fact that hospitals and specialist wound care facilities are seeking to embrace sophisticated technologies to heal chronic wounds and treat diabetic foot ulcers. Thus, the high prevalence of chronic, non-healing wounds, in addition to the increasing incidence of diabetes, and the consequent necessity to prevent infection and avoid amputation, will boost the demand for hyperbaric oxygen therapy chambers.

Regional Insights

North America dominates the hyperbaric oxygen therapy devices market. Innovative product development is set to benefit the industry as manufacturers continue to focus on improving patient’s comfort, optimizing space, enhancing the safety, and leveraging technology to make hyperbaric chambers more intelligent. For instance, Perry Baromedical has developed a SIGMA 40 monoplace chamber that offers the largest internal diameter measuring 40.5 inches allowing room for patients weighing up to 700 pounds.

Besides, the large size, the chamber also has a reduced weight by 1650 pounds compared to its predecessors, thus, offering improved comfort and reducing the risk of claustrophobia. In addition, the company also has SIGMA Elite, a computerized chamber platform and a compact SIGMA ICON 30 monoplace chamber that is ideal for facilities with limited space but requires advanced pneumatic features and two-way communication.

Besides, the Asia Pacific is expected to grow at the highest CAGR over the forecast period. The growth of the regional market is primarily driven by the increasing healthcare expenditure, the rising number of hospitals, the growing awareness about hyperbaric oxygen therapy, and the prevalence of chronic diseases and non-healing wounds. Moreover, countries like China, India, Japan, South Korea, and Australia are investing more in advanced medical technologies.

The rising number of speciality hospitals and wound care centers is also contributing to the growth of the market as these institutions provide hyperbaric oxygen therapy. In addition, medical tourism in the Asia Pacific region is gaining popularity, which is creating growth opportunities for the hyperbaric oxygen therapy market. Many private hospitals are emerging and offering advanced treatment to both local and foreign patients.

Recent Developments

• In December 2025, Holland Hospital announced the expansion and enhancement of its comprehensive Wound Healing & Hyperbaric Medicine Program, offering West Michigan patients access to advanced, hospital-based treatment for chronic and complex wounds. This expansion includes the launch of state-of-the-art Hyperbaric Oxygen Therapy (HBOT) in a newly remodeled suite, significantly elevating the level of specialized care available to local residents.

List of the prominent players in the Hyperbaric Oxygen Therapy Devices Market:

• Sechrist Industries Inc.
• Perry Baromedical Corporation
• Environmental Tectonics Corporation (ETC)
• HAUX-LIFE-SUPPORT GmbH
• Fink Engineering Pty Ltd.
• OxyHealth LLC / OxyHeal Health Group
• Gulf Coast Hyperbarics Inc.
• HEARMEC Co. Ltd.
• Hyperbaric SAC
• IHC Hytech B.V. / Royal IHC
• Hyperbaric Modular Systems (HMS)
• Pan America Hyperbarics, Inc.
• AHA Hyperbarics GmbH
• Tekna Manufacturing Inc.
• BioBarica
• BAROKS Hyperbaric
• OxyVal Hyperbaric
• OxyAir Hyperbaric Technology
• Hyperbaric Medical Solutions
• Airox Technologies Ltd.